AstraZeneca PLC is 5.3x more valuable than Sanofi by market capitalization ($286.27 B vs $53.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SNY | AZN |
|---|---|---|
| Market cap | $53.96 B | $286.27 B |
| US-listed rank | #308 | #49 |
| SEC filings | 981 | 1,004 |
AstraZeneca PLC is 5.3x more valuable than Sanofi by market capitalization ($286.27 B vs $53.96 B).
Full pages: Sanofi and AstraZeneca PLC, or browse the full rankings.